To: All persons and/or entities who purchased common stock in Provectus Biopharmaceuticals, Inc. (PVCT) during the period from Dec 17, 2013 to May 22, 2014 , and were damaged thereby; a settlement has been announced in the securities litigation known as Provectus Biopharmaceuticals, Inc. Securities Litigation, Civil Action No. 3:14-cv-00338-PLR-HBG, United States District Court for the Eastern District of Tennessee. For additional information about this settlement, please see the Notice and Proof of Claim (links provided below):
Claim submission deadline is November 25, 2016.
If you have any questions about the settlement, please contact the Claims Administrator. Their contact information can be found in the attached Notice.
Contact Us for
10205 North Pennsylvania Avenue, Oklahoma City, Oklahoma 73120Ph: 405.235.1560 Fax: 405.239.2112
Copyright © 2017 Federman & Sherwood. All Rights Reserved.